Arthritis, Psoriatic: all 594 studies

Page 3 of 6. Open to participants first (132), then studies with results posted, then the rest; newest registration first within each.

• Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From RemicadeCompletedNCT02605642Results posted
• A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic ArthritisCompletedNCT02584855Phase 3Results posted
• Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)CompletedNCT02538341Phase 2Results posted
• A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.CompletedNCT02486302Results posted
• Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment [WPAI])CompletedNCT02414633Results posted
• Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic ArthritisCompletedNCT02404350Phase 3Results posted
• Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic ArthritisCompletedNCT02376790Phase 3Results posted
• A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)CompletedNCT02349451Phase 2Results posted
• A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic ArthritisCompletedNCT02349295Phase 3Results posted
• Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)CompletedNCT02319759Phase 2Results posted
• 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic ArthritisCompletedNCT02294227Phase 3Results posted
• A Study of Golimumab in Participants With Active Psoriatic ArthritisCompletedNCT02181673Phase 3Results posted
• A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating MothersCompletedNCT02154425Phase 1Results posted
• Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis PatientsCompletedNCT02065713Phase 3Results posted
• Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic ArthritisTerminatedNCT02029495Phase 3Results posted
• To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)CompletedNCT02028169Results posted
• Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic ArthritisCompletedNCT02024646Phase 3Results posted
• A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the PlacentaCompletedNCT02019602Phase 1Results posted
• 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic ArthritisCompletedNCT01989468Phase 3Results posted
• Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type PsoriasisCompletedNCT01988103Phase 2Results posted
• Open-Label Extension Study Of Tofacitinib In Psoriatic ArthritisCompletedNCT01976364Phase 3Results posted
• Safety and Efficacy Study of Apremilast to Treat Psoriatic ArthritisCompletedNCT01925768Phase 3Results posted
• Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject EtanerceptCompletedNCT01901185Phase 3Results posted
• Extension Study up to 3 Years for Secukinumab in Psoriatic ArthritisCompletedNCT01892436Phase 3Results posted
• Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF InhibitorsCompletedNCT01882439Phase 3Results posted
• Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator StudyCompletedNCT01877668Phase 3Results posted
• Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic ArthritisCompletedNCT01860976Phase 3Results posted
• Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in BelgiumCompletedNCT01845818Results posted
• The Effect of n-3 Polyunsaturated Fatty Acids in Patients With Psoriatic ArthritisCompletedNCT01818804Not applicableResults posted
• Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical PracticeCompletedNCT01768858Results posted
• Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic ArthritisCompletedNCT01752634Phase 3Results posted
• A Study of Ixekizumab in Participants With Active Psoriatic ArthritisCompletedNCT01695239Phase 3Results posted
• Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque PsoriasisCompletedNCT01690299Phase 3Results posted
• A Clinical Study of Increased Dose of TA-650 in Patients With PsoriasisCompletedNCT01680159Phase 3Results posted
• A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic ArthritisCompletedNCT01519089Phase 3Results posted
• AMG 827 in Subjects With Psoriatic ArthritisTerminatedNCT01516957Phase 2Results posted
• Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) TherapyCompletedNCT01490450Phase 2Results posted
• Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic ArthritisCompletedNCT01474876Results posted
• Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)CompletedNCT01392326Phase 3Results posted
• Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab TreatmentCompletedNCT01316224Results posted
• A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)CompletedNCT01313858Results posted
• Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)CompletedNCT01307423Phase 3Results posted
• Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With AdalimumabCompletedNCT01282372Results posted
• Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With AdalimumabCompletedNCT01273519Results posted
• PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisCompletedNCT01212770Phase 3Results posted
• PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisCompletedNCT01212757Phase 3Results posted
• Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)CompletedNCT01198509Not applicableResults posted
• Efficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisCompletedNCT01172938Phase 3Results posted
• Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic ArthritisCompletedNCT01169844Phase 2Results posted
• Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical CareCompletedNCT01163916Results posted
• Special Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis (All Patients Investigation)CompletedNCT01155570Results posted
• Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology PracticeCompletedNCT01147874Phase 4Results posted
• Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis in Normal Medical PracticeCompletedNCT01111240Results posted
• Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic ArthritisCompletedNCT01087788Phase 3Results posted
• Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic DrugsCompletedNCT01083693Results posted
• Surveillance of Humira Injection in Korean PatientsCompletedNCT01083121Results posted
• A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )CompletedNCT01078558Results posted
• EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European CountriesCompletedNCT01078402Results posted
• A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF AgentsCompletedNCT01077362Phase 3Results posted
• T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF BlockadeCompletedNCT01060098Results posted
• A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic ArthritisCompletedNCT01009086Phase 3Results posted
• Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic ArthritisCompletedNCT00938015Results posted
• Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic ArthritisCompletedNCT00809614Phase 2Results posted
• Single Dose PG102 in Patients With Active Psoriatic ArthritisTerminatedNCT00787137Phase 1Results posted
• An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis ParticipantsCompletedNCT00760669Results posted
• Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)CompletedNCT00727298Results posted
• Investigation of 9 Consecutive Infusions of Remicade for Psoriatic Arthritis in Austria (Study P04264)CompletedNCT00725296Results posted
• Study Evaluating the Safety of Enbrel (Etanercept)CompletedNCT00683384Results posted
• Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic ArthritisTerminatedNCT00534313Phase 2Results posted
• Centocor Microarray Study of PatientsCompletedNCT00462072Phase 4Results posted
• Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic ArthritisCompletedNCT00456092Phase 2Results posted
• Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422)CompletedNCT00367237Phase 3Results posted
• Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional TherapyCompletedNCT00303186Results posted
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by RheumatologistsCompletedNCT00293722Results posted
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by DermatologistsCompletedNCT00293709Results posted
• Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic ArthritisTerminatedNCT00273858Results posted
• An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic ArthritisCompletedNCT00267956Phase 2Results posted
• A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic ArthritisCompletedNCT00265096Phase 3Results posted
• Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic ArthritisCompletedNCT00245960Phase 4Results posted
• PsA Treatment With hOKT3γ1 (Ala-Ala)TerminatedNCT00239720Phase 2Results posted
• REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)CompletedNCT00127842Phase 4Results posted
• Prospective Analysis of Blood Flow Restriction Training in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Compared to Conventional Strength TrainingCompletedNCT07772687Not applicable
• Construct Validity and Responsiveness of EQ-5D-3L and EQ-5D-5L in Patients With Inflammatory Joint DiseaseCompletedNCT07580092
• Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Active, not recruitingNCT07486960Phase 2
• Upadacitinib Versus IL-17 Inhibitors in Patients With Psoriatic ArthritisCompletedNCT07386717
• Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease ActivityCompletedNCT07277491
• Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab TherapyWithdrawnNCT07255781
• Effects of IL17/23 Inhibitors on Markers of Subclinical Atherosclerosis in Patients With PsoriasisCompletedNCT07169682
• A Study of SPY072 in Rheumatic DiseaseActive, not recruitingNCT07148414Phase 2
• Artificial Intelligence Literacy and E-Health Literacy in Rheumatic DiseasesCompletedNCT07054749
• Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic PredictorsCompletedNCT07041112
• A Randomized, Double-blind Clinical Trial on the Efficacy of a Dietary Formulation Containing Medium-chain Triglycerides (MCT) and Fiber in Patients With Psoriatic ArthritisCompletedNCT06990152Not applicable
• A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic ArthritisActive, not recruitingNCT06878404Phase 3
• A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)Active, not recruitingNCT06864026Phase 4
• IKBKB Gene Polymorphism (Single Nucleotide Polymorphism) (SNP) in Psoriatic and Psoriatic Arthritis PatientsCompletedNCT06729463Not applicable
• A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi ArabiaCompletedNCT06714461
• Psoriatic Arthritis Pathobiology and Its Relationship With Clinical Disease ActivityCompletedNCT06676176
• A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesActive, not recruitingNCT06671496Phase 3
• COMFI - a COMbined Fatigue InterventionCompletedNCT06666452Not applicable
• Psoriatic Disease and Related Manifestations; Real World Evidence in Brazilian Secukinumab EnvironmentCompletedNCT06666114

← Arthritis, Psoriatic overview